Biocon to consider Q3 results

On 24 January 2017
Biocon announced that a meeting of the Board of Directors of the Company will be held on 24 January 2017, inter alia, to consider, approve and take on record, the un-audited financial results (both standalone and consolidated) of the Company for the quarter ended 31 December 2016 (Q3) amongst other routine matters.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Dec 27 2016 | 2:01 PM IST
